{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:30:51Z","timestamp":1761611451324,"version":"3.41.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Science and Technology Major Projects for Major New Drugs Innovation and Development","award":["2018ZX09301028"],"award-info":[{"award-number":["2018ZX09301028"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jchromb.2018.06.004","type":"journal-article","created":{"date-parts":[[2018,6,2]],"date-time":"2018-06-02T06:19:56Z","timestamp":1527920396000},"page":"95-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pharmacokinetic, bioavailability and tissue distribution study of MP3950, a new gastroprokinetic candidate compound, in rat using UPLC-MS\/MS"],"prefix":"10.1016","volume":"1092","author":[{"given":"Yu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8562-7280","authenticated-orcid":false,"given":"Feng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhili","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaojie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhonggui","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longshan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2018.06.004_bb0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ddstr.2007.11.001","article-title":"Novel approaches and clinical opportunity for gastrointestinal prokinetic drugs","volume":"4","author":"Borman","year":"2007","journal-title":"Drug Discovery Today Ther. Strateg."},{"key":"10.1016\/j.jchromb.2018.06.004_bb0010","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.dld.2011.10.009","article-title":"Natural history of functional gastrointestinal disorders: comparison of two longitudinal population-based studies","volume":"44","author":"Olafsdottira","year":"2012","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.jchromb.2018.06.004_bb0015","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1111\/j.1572-0241.2002.05783.x","article-title":"Epidemiology and health care seeking in the functional GI disorders: a population-based study","volume":"97","author":"Koloski","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jchromb.2018.06.004_bb0020","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1053\/j.gastro.2007.06.010","article-title":"Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study","volume":"133","author":"Halder","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jchromb.2018.06.004_bb0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.diabres.2009.09.024","article-title":"The effect of mosapride citrate on constipation in patients with diabetes","volume":"87","author":"Ueno","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.jchromb.2018.06.004_bb0030","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jdiacomp.2008.01.001","article-title":"Rapid effect of mosapride citrate, 5-HT4 receptor agonist, on fasting blood glucose in Type 2 diabetes patients","volume":"23","author":"Ueno","year":"2009","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.jchromb.2018.06.004_bb0035","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.diabres.2009.12.021","article-title":"The effect of mosapride (5HT-4 receptor agonist) on insulin sensitivity and GLUT4 translocation","volume":"87","author":"Nam","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.jchromb.2018.06.004_bb0040","unstructured":"S.J.W. L.S. Zhao, Z.G. He, Y.F. Song, China Patent, 2015."},{"key":"10.1016\/j.jchromb.2018.06.004_bb0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jpba.2009.03.011","article-title":"Characterization of metabolic profile of mosapride citrate in rat and identification of two new metabolites: mosapride N -oxide and morpholine ring-opened mosapride by UPLC\u2013ESI-MS\/MS","volume":"50","author":"Sun","year":"2009","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2018.06.004_bb0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jchromb.2016.08.012","article-title":"Development and validation of a chiral liquid chromatography method for the determination of MP 3950 enantiomers, a high selective 5-HT 4 receptor agonist, in rat plasma and its application to stereoselective pharmacokinetic study","volume":"1033\u20131034","author":"Wang","year":"2016","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2018.06.004_bb0055","first-page":"1","article-title":"Comparative pharmacokinetics of (S)-MP3950, a novel 5-HT4 receptor agonist, in normal and atropine-induced gastrointestinal motility disorders rats","author":"Wang","year":"2017","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jchromb.2018.06.004_bb0060","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jep.2012.05.047","article-title":"Pharmacokinetics, tissue distribution and metabolism of senkyunolide I, a major bioactive component in Ligusticum chuanxiong Hort. (Umbelliferae)","volume":"142","author":"He","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jchromb.2018.06.004_bb0065","first-page":"1095","article-title":"Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys","volume":"43","author":"Matsumoto","year":"1993","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.jchromb.2018.06.004_bb0070","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0731-7085(96)02006-7","article-title":"Simultaneous enantiomeric determination of a gastroprokinetic agent mosapride citrate and its metabolite in plasma using alpha 1-acid glycoprotein HPLC column","volume":"15","author":"Yokoyama","year":"1997","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2018.06.004_bb0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jchromb.2007.08.017","article-title":"Liquid chromatography-tandem mass spectrometric method for determination of mosapride citrate in equine tissues","volume":"858","author":"Aoki","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2018.06.004_bb0080","first-page":"1078","article-title":"Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals","volume":"43","author":"Yoshida","year":"1993","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.jchromb.2018.06.004_bb0085","first-page":"864","article-title":"Pharmacokinetics of the gastrokinetic agent mosapride citrate after intravenous and oral administrations in dogs and monkeys","volume":"43","author":"Sakashita","year":"1993","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.jchromb.2018.06.004_bb0095","unstructured":"Zhao L, Wang S, He Z, Song Y. Mosapride active metabolites, preparing method and application. CN Patent, CN 104961646A, publ."},{"key":"10.1016\/j.jchromb.2018.06.004_bb0100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jchromb.2016.08.012","article-title":"Development and validation of a chiral liquid chromatography method for the determination of MP 3950 enantiomers, a high selective 5-HT4 receptor agonist, in rat plasma and its application to stereoselective pharmacokinetic study","volume":"1033-1034","author":"Wang","year":"2016","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2018.06.004_bb0105","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3109\/00498254.2014.880201","article-title":"Structure identification and elucidation of mosapride metabolites in human urine, feces and plasma by ultra performance liquid chromatography-tandem mass spectrometry method","volume":"44","author":"Sun","year":"2014","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jchromb.2018.06.004_bb0110","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.talanta.2015.01.021","article-title":"Simultaneous determination of mosapride and its active des-p-fluorobenzyl and 4\u2032-N-oxide metabolites in rat plasma using UPLC\u2013MS\/MS: an application for a pharmacokinetic study","volume":"137","author":"Zhao","year":"2015","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2018.06.004_bb0115","first-page":"463","article-title":"Determination of cocaine metabolites and the adulterant levamisole in urine using UPLC-MS\/MS","author":"Abou-Diwan","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jchromb.2018.06.004_bb0120","first-page":"882","article-title":"Determination of mosapride in human plasma by high performance liquid chromatography tandem mass spectrometry","volume":"42","author":"Qin","year":"2007","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.jchromb.2018.06.004_bb0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0016-5085(89)90758-0","article-title":"Influence of gender and menopause on gastric emptying and motility","volume":"96","author":"Hutson","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jchromb.2018.06.004_bb0135","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00003088-200342020-00001","article-title":"The influence of sex on pharmacokinetics","volume":"42","author":"Schwartz","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jchromb.2018.06.004_bb0140","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10156-010-0095-z","article-title":"Involvement of sulfate conjugation and multidrug resistance-associated protein 2 (Mrp2) in sex-related differences in the pharmacokinetics of garenoxacin in rats","volume":"17","author":"Hayashi","year":"2011","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.jchromb.2018.06.004_bb0145","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.genm.2009.12.004","article-title":"Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: an updated review","volume":"6","author":"Bigos","year":"2009","journal-title":"Gend. Med."},{"key":"10.1016\/j.jchromb.2018.06.004_bb0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cnr.2005.08.004","article-title":"Sex- and gender-related differences in the neurobiology of drug abuse","volume":"5","author":"Lukas","year":"2005","journal-title":"Clin. Neurosci. Res."},{"key":"10.1016\/j.jchromb.2018.06.004_bb0155","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.drugalcdep.2014.03.023","article-title":"Sex differences in methamphetamine pharmacokinetics in adult rats and its transfer to pups through the placental membrane and breast milk","volume":"139","author":"Rambousek","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jchromb.2018.06.004_bb0160","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jep.2015.04.007","article-title":"UPLC-MS\/MS determination and gender-related pharmacokinetic study of five active ingredients in rat plasma after oral administration of Eucommia cortex extract","volume":"169","author":"Hu","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jchromb.2018.06.004_bb0165","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/toxsci\/kfj027","article-title":"Toxicity and tissue distribution of magnetic nanoparticles in mice","volume":"89","author":"Kim","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jchromb.2018.06.004_bb0170","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0022-3565(25)32259-7","article-title":"Oxazepam kinetics: effects of age and sex","volume":"215","author":"Greenblatt","year":"1980","journal-title":"J. Pharmacol. Exp. Ther."},{"year":"2009","series-title":"Study on the Metabolism and Pharmacokineticstics of Mosapride","author":"Sun","key":"10.1016\/j.jchromb.2018.06.004_bb0175"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023217318779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023217318779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T23:14:43Z","timestamp":1751670883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023217318779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":33,"alternative-id":["S1570023217318779"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2018.06.004","relation":{},"ISSN":["1570-0232"],"issn-type":[{"type":"print","value":"1570-0232"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetic, bioavailability and tissue distribution study of MP3950, a new gastroprokinetic candidate compound, in rat using UPLC-MS\/MS","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2018.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}